An update on regulatory T cells in transplant tolerance and rejection

Nature Reviews Nephrology

Volumn 6, Issue 10, 2010, Pages 577-583

  Li, Xian Chang ^a   Turka, Laurence A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AUTOANTIGEN; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CROSS REACTION; GRAFT REJECTION; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOID TISSUE; MEMORY T LYMPHOCYTE; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; THYMUS; TISSUE REPAIR; TRANSPLANTATION TOLERANCE;

ANIMALS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 77957558616     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2010.101     Document Type: Review

References (61)

1. Lechler, R., Garden, O. A. & Turka, L. A. The complementary roles of deletion and regulation in transplantation tolerance. Nat. Rev. Immunol. 3, 147-158 (2003).
2. Strom, T. B. & Koulmanda, M. Recently discovered T cell subsets cannot keep their commitments. J. Am. Soc. Nephrol. 20, 1677-1680 (2009).
3. +) T cells. Curr. Opin. Immunol. 21, 281-285 (2009).
4. + Tregs. Blood 110, 2501-2510 (2007).
5. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
6. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
7. Zhang, Z. X., Yang, L., Young, K. J., Du Temple, B. & Zhang, L. Identification of a previously unknown antigen-specific regulatory T cells and its mechanism of suppression. Nat. Med. 6, 782-789 (2000).
8. Seino, K.-I. et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl Acad. Sci. USA 98, 2577-2581 (2001).
9. Wood, K. J. & Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3, 199-210 (2003).
10. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
11. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005).
12. + regulatory T cells: more of the same or a division of labor? Immunity 30, 626-635 (2009).
13. + regulatory T cells. J. Immunol. 182, 6736-6743 (2009).
14. Gao, W. et al. Contrasting effects of cyclosporine and rapamycin on de novo generation of antigenspecific regulatory T cells. Am. J. Transplant. 7, 1722-1732 (2007).
15. + regulatory T cells. Nat. Immunol. 9, 632-640 (2008).
16. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
17. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341 (2005).
18. Waldmann, H. Transplantation tolerance-where do we stand? Nat. Med. 5, 1245-1248 (1999).
19. Benson, M. J., Pino-Lagos, K., Rosemblatt, M. & Noelle, R. J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J. Exp. Med. 204, 1765-1774 (2007).
20. Gao, W. et al. Treg versus Th17 lymphocyte lineages are cross-regulated by LIF versus IL-6. Cell Cycle 8, 1444-1450 (2009).
21. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029 (2009).
22. + regulatory T cells. Proc. Natl Acad. Sci. USA 104, 18169-18174 (2007).
23. + cells. J. Exp. Med. 205, 565-574 (2008).
24. Lal, G. & Bromberg, J. S. Epigenetic mechanisms of regulation of Foxp3 expression. Blood 114, 3727-3735 (2009).
25. Wong, J., Mathis, D. & Benoist, C. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204, 2039-2045 (2007).
26. + T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
27. + Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 119, 2898-2913 (2009).
28. + regulatory T lymphocytes. Nat. Med. 14, 88-92 (2008).
29. Deaglio, S. et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265 (2007).
30. + regulatory T cell function. Science 322, 271-275 (2008).
31. Bettni, M. & Vignali, D. A. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr. Opin. Immunol. 21, 612-618 (2009).
32. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T cell function. Nature 450, 566-569 (2007).
33. You, S. et al. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl Acad. Sci. USA 104, 6335-6340 (2007).
34. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGF-beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing cells. Immunity 24, 179-189 (2006).
35. Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007 (2009).
36. Wan, Y. Y. & Flavell, R. A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 (2007).
37. Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56 (2008).
38. Zhou, X. et al. Selective miRNA disruption in Treg cells leads to uncontrolled autoimmunity. J. Exp. Med. 205, 1983-1991 (2008).
39. + antigenspecific autoimmune effectors in vitro and in vivo. J. Immunol. 181, 3137-3147 (2008).
40. Li, X. C., Rothstein, D. M. & Sayegh, M. H. Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229, 271-293 (2009).
41. Lu, L. F. et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91 (2009).
42. Auchincloss, H. Jr. & Sultan, H. Antigen processing and presentation in transplantation. Curr. Opin. Immunol. 8, 681-687 (1996).
43. Rulifson, I. C., Szot, G. L., Palmer, E. & Bluestone, J. A. Inability to induce tolerance through direct antigen presentation. Am. J. Transplant. 2, 510-519 (2002).
44. Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796 (2001).
45. Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930-939 (2009).
46. Graca, L., Cobbold, S. P. & Waldmann, H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195, 1641-1646 (2002).
47. Zhang, N. et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30, 458-469 (2009).
48. Surh, C. D., Boyman, O., Purton, J. F. & Sprent, J. Homeostasis of memory T cells. Immunol. Rev. 211, 154-163 (2006).
49. Qin, S. et al. "Infectious" transplantation tolerance. Science 259, 974-977 (1993).
50. + T cell tolerance and linked suppression. J. Immunol. 163, 4805-4810 (1999).
51. Yang, J. et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl Acad. Sci. USA 104, 19954-19959 (2007).
52. Korn, T. et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431 (2007).
53. Roy, S. et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J. Immunol. 180, 1729-1736 (2008).
54. Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345-354 (2007).
55. Seddiki, N. et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700 (2006).
56. + T reg cells. J. Exp. Med. 203, 1701-1711 (2006).
57. + T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911 (2009).
58. + Tregs. J. Clin. Invest. 115, 3276-3284 (2005).
59. + T regulatory cell development during the neonatal period. J. Exp. Med. 201, 769-777 (2005).
60. Zheng, X. X. et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 19, 503-514 (2003).
61. Webster, K. E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751-760 (2009).